The Diabetes Bonanza – Part I
Diabetes contributes billions of dollars to the coffers of Healthcare Industry. The worldwide sales of diabetes drugs was 27.3 billion in 2008, in 2013 it totaled $41 billion, and is expected to cross the $55 billion mark in 2016 . . .
The US has the dominant share in the global diabetes market, with $21 billion in drug sales and a total cost of $198 billion to the people in 2013 – That means $198 billion in revenue for the Healthcare Industry. And, the diabetes segment of the industry is expected to maintain its double-digit growth rate . . .
